Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Brett

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Biorxiv : the Preprint Server for Biology|December 10, 2020
A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamstersTraci L Bricker, Tamarand L Darling, Ahmed O Hassan, et al.
Cell Reports|July 10, 2021
A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamstersTraci L Bricker, Tamarand L Darling, Ahmed O Hassan, et al.
Nature Communications|January 30, 2024
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffoldsEike-Christian Wamhoff, Larance Ronsard, Jared Feldman, et al.
Cell Host & Microbe|June 30, 2021
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and diseaseJames Brett Case, Rita E Chen, Longxing Cao, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesisJames Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Mbio|March 8, 2018
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading ExoribonucleaseMaria L Agostini, Erica L Andres, Amy C Sims, et al.
Nature Chemical Biology|November 21, 2022
A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPinsVikas Chonira, Young D Kwon, Jason Gorman, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2021
A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitopeLaura VanBlargan, Lucas Adams, Zhuoming Liu, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|December 10, 2020
A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamstersTraci L Bricker, Tamarand L Darling, Ahmed O Hassan, et al.
Cell Reports|July 10, 2021
A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamstersTraci L Bricker, Tamarand L Darling, Ahmed O Hassan, et al.
Nature Communications|January 30, 2024
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffoldsEike-Christian Wamhoff, Larance Ronsard, Jared Feldman, et al.
Cell Host & Microbe|June 30, 2021
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and diseaseJames Brett Case, Rita E Chen, Longxing Cao, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesisJames Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Mbio|March 8, 2018
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading ExoribonucleaseMaria L Agostini, Erica L Andres, Amy C Sims, et al.
Nature Chemical Biology|November 21, 2022
A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPinsVikas Chonira, Young D Kwon, Jason Gorman, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in miceBaoling Ying, Suzanne M Scheaffer, Bradley Whitener, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2021
A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitopeLaura VanBlargan, Lucas Adams, Zhuoming Liu, et al.
Pageof 11